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A META-ANALYSIS OF FMRI STUDIES ON EMOTION PROCESSING IN  
MAJOR DEPRESSIVE DISORDER 
 
by Madison Morocco 
 
The processing of an emotional stimulus involves a multi-step process that includes 
appraising and identifying a stimulus as well as producing an affective state in response. 
Many individuals with depressive disorders such as major depressive disorder (MDD) 
experience impairments related to emotion processing, likely caused by changes in the 
structure and function of brain regions important for emotion processing. However, the 
precise neural differences underlying emotion processing impairments in MDD remain 
unclear given conflicting findings in the neuroimaging literature. This lack of clarity has 
hindered the development of novel neurostimulation treatments for MDD, which require 
targeting of specific brain areas. In an effort to better identify specific areas of the brain 
to target for stimulation treatment, I conducted a meta-analysis of the functional magnetic 
resonance imaging (fMRI) literature to date regarding emotion processing in MDD. The 
meta-analysis of fMRI studies examined emotion processing in healthy controls and 
individuals with MDD using the tool GingerALE. Results showed clusters of 
hyperactivity in the amygdala and portions of the ventral basal ganglia, a finding that 
held true when limiting the analysis to only those studies that utilized negative stimuli. 
Additional exploratory results showed a cluster of hypoactivity in the right dorsolateral 
prefrontal cortex. These results help to shed light on neural changes underlying emotion 
processing in MDD, and may serve to inform future neurostimulation clinical trials. 
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Major depressive disorder (MDD) is a depressive disorder that affects approximately 
20% of the U.S. population at some point in their lives, making it one of the most 
prevalent of all psychiatric disorders (Joormann & Quinn, 2014). MDD is characterized 
by several symptoms that can greatly affect an individual’s quality of life (Wang et al., 
2019). Symptoms of MDD include low mood, fatigue, loss of interest in activities, and 
poor emotion processing (Park, et al., 2019; Wang et al., 2019). Indeed, MDD has a 
negative impact on quality of life, such that MDD is a leading global cause of disability 
(Murray et al., 2015). 
Although numerous studies have demonstrated alterations in emotion processing in 
MDD, the neural mechanisms underlying these alterations remain unclear, making the 
development of novel treatments challenging (Stuhrmann, Suslow, & Dannlowski, 2011). 
There are several types of efficacious treatments for MDD, including specific 
psychotherapies and pharmacotherapy (Wang et al., 2019), but 50% of individuals with 
MDD do not respond to these treatments (Akechi et al., 2020), and therefore experience a 
continued negative impact on quality of life (Wang et al., 2019).  
For individuals with treatment resistant depression (TRD), newer types of treatment 
are being evaluated in clinical trials, including forms of neural stimulation such as deep 
brain stimulation (DBS) and transcranial magnetic stimulation (TMS), as well as 
intranasal ketamine (Pradhan, Parikh, Makani, & Sahoo, 2015). Whereas ketamine has 
systemic effects, DBS and TMS require targeted stimulation of specific brain areas. 
Preliminary findings from neurostimulation trials have revealed mixed findings in terms 
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of the effectiveness of DBS and TMS (Filkowski & Sheth, 2019; Wang, 2019), such that 
more research is needed to identify optimal areas to target for treatment. A recent review 
by Filkowski and Sheth (2019) suggests that gaps in the literature have contributed to the 
field’s inability to identify specific areas of the brain to target for stimulation treatment in 
TRD. In an effort to address this issue, I performed a meta-analysis of functional MRI 
(fMRI) studies comparing brain activity during emotion processing in individuals with 
MDD and healthy controls to discern valuable information regarding areas of dysfunction 
in MDD, and thus potential areas for treatment.  
Neural Bases of Emotion Processing  
Emotional responses involve a complicated, multi-dimensional process that changes 
over time with respect to latency, rise time, magnitude, and duration (Gross, 2002). We 
may feel negative emotions after hearing a hurtful comment, positive emotions after 
witnessing an awe-inspiring moment, or neutral emotions after relaxing. Regardless of 
the kind of emotion, these coordinated behavioral, experiential, and physiological 
response tendencies influence how we respond to our perceived challenges and 
opportunities (Gross, 2002). With respect to the neuropsychological basis of such 
responses, Phillips, Drevets, Rauch, and Lane (2003) propose that the following 
processes occur after exposure to an emotional stimulus: (1) appraisal and identification 
of the emotional significance of the stimulus, (2) production of a specific affective state 
in response to the stimulus, and (3) regulation of the affective state and emotional 
behavior. For the purposes of this meta-analysis, I focused on neural processes supporting 
the first two stages, henceforth referred to as emotion processing. 
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Previous neuroimaging research has linked emotion processing to several areas of the 
prefrontal cortex and limbic system. Specifically, these areas include the medial 
prefrontal cortex, dorsolateral prefrontal cortex, ventrolateral prefrontal cortex, anterior 
cingulate cortex, orbitofrontal cortex, and the amygdala (Ahmed, Bittencourt-Hewitt, & 
Sebastian, 2015; Yoo, Gujar, Hu, Jolesz, & Walker, 2007). Each of these regions plays a 
role in emotion processing, whether it be expressing emotions (medial prefrontal cortex 
and anterior cingulate cortex) or the emotionality of reward-based processing (e.g., 
gambling; orbitofrontal cortex) (Ahmed et al., 2015; Barbas, 2007; Blakemore, 2008; 
Davidson, Putnam, & Larson, 2000; Etkin, Egner, & Kalisch, 2011; Gasquoine, 2013). 
Additionally, the amygdala has been linked to emotion regulation, emotion response, 
emotional memory, and emotional learning in healthy individuals (LeDoux, 2000). Given 
the significance of the prefrontal cortex and limbic system in emotion processing, and 
given that impaired emotion processing is a common symptom of MDD, many 
researchers have examined whether and how activity in these areas differs in individuals 
with MDD relative to healthy controls.  
Emotion Processing in MDD 
Impaired emotion processing in MDD can manifest in a variety of ways. For 
example, individuals with MDD tend to rate negative stimuli as more negative than 
healthy individuals (Fonseka, Jaworska, Courtright, MacMaster, & MacQueen, 2016), 
and they have increased accessibility of negative memories and decreased accessibility of 
positive memories (Joormann & Quinn, 2014). Further, multiple studies show that 
individuals with MDD are more likely to remember negative words and negative 
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autobiographical memories than positive words and positive autobiographical memories 
(Joormann & Quinn, 2014; Matt, Vázquez, & Campbell, 1992). These cognitive biases 
suggest that individuals with MDD may show abnormal patterns of activity in the 
abovementioned regions supporting emotion processing (Gotlib & Joormann, 2010; 
Kaiser et al., 2015).  
fMRI studies of emotion processing in people with MDD typically involve examining 
brain activity in response to emotional vs. neutral stimuli (Canli et al., 2004; Epstein et 
al., 2006; Lang, Bradley, & Cuthbert, 1997; Sacchet et al., 2017). For example, 
participants would view emotional images (e.g., angry or crying people, spiders, or a 
cemetery) as well as neutral images (e.g., a wall or geometric shapes), and neural 
responses to each image type would be compared in individuals with MDD as well as 
healthy controls. Studies using this approach have reported dysfunctional activity in 
MDD in both the amygdala and prefrontal cortex in individuals. Studies using negative 
images from the International Affective Picture System (IAPS;Lang, Bradley, & 
Cuthbert, 1997) have reported greater activity (i.e., hyperactivity) in MDD relative to 
controls in several regions of the frontal lobe (supplemental motor area, bilateral 
prefrontal cortex, dorsolateral prefrontal cortex, right lateral orbitofrontal cortex, right 
medial orbitofrontal cortex) as well as the dorsal anterior cingulate cortex, right middle 
temporal gyrus, amygdala, insula, and thalamus (Davis et al., 2019; Johnstone et al., 
2007; Rosenblau et al. 2012; Tozzi et al., 2017).  
Another common task, called the Facial Emotion Perception Test (FEPT), features 
images of people making emotional or neutral facial expressions in which participants are 
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asked to categorize each face by emotion (anger, happiness, sadness, fear, or neutral) 
using a 5-button response box (Jenkins et al., 2017). Brain activity in response to each 
image type is then compared in individuals with MDD and controls. An fMRI study 
using the FEPT demonstrated hyperactivity in the amygdala, insula, and subgenual 
anterior cingulate cortex in MDD relative to controls when viewing emotional faces 
(Jenkins et al., 2017), findings that are consistent with some, but not all, of the 
abovementioned results. 
 Another commonly used task involves presenting participants with sets of emotional 
and neutral words or word pairs (Canli et al., 2004; Epstein et al., 2006; Sacchet et al., 
2017). Results have demonstrated hyperactivity in the right middle frontal gyrus, 
amygdala, hippocampus, and inferior parietal lobule in MDD relative to controls when 
processing negative emotional stimuli (Canli et al., 2004; Sacchet et al., 2017). However, 
individuals with MDD demonstrated less activity (i.e., hypoactivity) than controls when 
processing positive emotional stimuli in the bilateral ventral striatal, dorsomedial frontal 
region, superior temporal gyrus, cerebellum, and dorsolateral prefrontal cortex (Canli et 
al., 2004; Epstein et al., 2006). The dorsolateral prefrontal cortex, in particular, is a 
disputed region as it has been shown to be both hyper- and hypoactive in individuals with 
MDD compared to HC in different studies (Groenewold, Opmeer, de Jonge, Aleman, & 
Costafreda, 2013; Rosenblau et al. 2012).  
Several reviews of this literature have been published (e.g., Dichter, Gibbs, & 
Smoski, & 2015; Jaworska, Yang, Knott, MacQueen, & 2015; Rive et al., 2013; 
Stuhrmann et al., 2011; Young et al., 2018), as well as one prior meta-analysis of emotion 
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processing in MDD (Groenewold et al., 2013). Groenewold et al. (2013) found that 
participants with MDD showed dysfunction in the amygdala, striatum, parahippocampal 
cortex, cerebellum, fusiform gyrus, and anterior cingulate cortex during emotion 
processing tasks. Interestingly, the direction of the dysfunction (i.e., hyper- or 
hypoactivation in MDD relative to controls) depended on the valence of the stimuli. For 
example, viewing negatively-valenced stimuli resulted in hyperactivation of these regions 
in MDD, while viewing positively-valenced stimuli resulted in hypoactivation of the 
same regions. Critically, in the time since this meta-analysis was published, multiple 
relevant fMRI studies have been reported, creating an opportunity to repeat these 
analyses with newer data and a larger sample size.  
Taken together, studies of emotion processing in MDD have revealed areas of both 
increased and decreased neural activity relative to controls. Across several studies, the 
amygdala, insula, frontal cortex, and cingulate cortex areas have been shown to be 
hyperactive in MDD relative to controls. Conversely, a small number of studies have 
indicated that the superior temporal gyrus, cerebellum, bilateral ventral striatal, and 
dorsomedial frontal areas are hypoactive in MDD relative to controls. It also bears noting 
that several other areas (e.g., supplemental motor area, right middle temporal gyrus, 
thalamus, right inferior frontal sulcus) have been reported to show dysfunction in MDD, 
but such findings come from single studies and have not been replicated.  
Given the lack of consistency in the literature to date, greater clarification regarding 
areas of dysfunction during emotion processing in MDD is needed to better inform 
clinical trials of DBS and TMS, potentially improving treatment efficacy and thereby the 
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patients’ quality of life (Kisely, Li, Warren, & Siskind, 2018; Liu, Sheng, Li, & Zhang, 
2017). To address this issue, I conducted a meta-analysis of functional neuroimaging 
studies of emotion processing in MDD to synthesize the current literature and determine 
whether one or more regions are consistently shown to be hyper- and/or hypoactive in 
this population.  
Aim and Hypothesis 
Since Groenewold et al.’s meta-analysis was published in 2013, more than 20 
emotion processing studies have been published that have the potential to better inform 
current understanding of brain regions exhibiting dysfunction in MDD during emotion 
processing. As such, I conducted an fMRI meta-analysis of emotion processing in MDD 
inclusive of fMRI studies published through 2020. Studies pertaining to emotion 
regulation were excluded given that the tasks used are quite different. Such studies 
typically use stimuli similar to those in emotion processing studies, but participants are 
asked to actively regulate their emotions in response to these the stimuli instead of 
passively view them. As more fMRI studies of emotion regulation in MDD are published 
in the future, researchers can conduct meta-analyses of this literature.  
A meta-analysis not only synthesizes vast amounts of research, but critically, it also 
allows for statistical analysis of prior findings and provides quantitative results, unlike a 
qualitative review (Gravetter, Wallnau, Forzano, & Witnauer, 2020). In the current study, 
I aimed to answer the following questions: (1) in fMRI studies of emotion processing in 
MDD, which regions consistently demonstrate impairments in emotion processing?, (2) 
for each of these areas, do individuals with MDD demonstrate greater or lesser activity 
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than controls when processing emotional stimuli, (3) are these effects related to stimulus 
valence?  
Based on a qualitative review of the fMRI literature and the meta-analytic findings of 
Groenewold et al. (2013), I hypothesized that prefrontal cortex regions, the anterior 
cingulate cortex, and the amygdala would be consistently more active in patients relative 
to controls when performing an emotion processing task. Further, I hypothesized that 
these findings would hold true when including only those studies that focused on 
negative stimuli, specifically. Lastly, I hypothesized that the dorsomedial frontal regions, 
the dorsolateral prefrontal cortex, and bilateral ventral striatal would be consistently less 
















Overview          
I conducted a meta-analysis of the fMRI literature to date regarding emotion 
processing in MDD using GingerALE (http://www.brainmap.org; Laird, Lancaster,  Fox, 
& Uecker, 2003), a software program for manually performing fMRI meta-analyses. 
Study Selection  
To select studies to be included, I conducted a literature review using the databases 
PsycINFO and PubMed and the search terms “Major Depressi(*) AND emotion 
processing AND fMRI”. Relevant papers were included that met the following criteria: 
(1) studies that compare individuals with a current MDD diagnosis (no comorbid 
disorders) to individuals in a healthy control group, (2) studies that use an emotion 
processing task that involves both emotional and neutral stimuli, and (3) studies that use 
participants that are young to middle-aged adults (18 - 60). The latter was chosen to avoid 
confounds associated with structural and functional differences in older adults. My 
literature review indicated that 30 studies met these criteria, published between 2004 and 
2019. Table 1 includes a list of these studies along with the number of participants in 
each group, specific task and stimuli used, conditions compared for statistical purposes, 















Meta-Analytic Procedure  
GingerALE is a free software tool for manually conducting fMRI meta-analyses. This 
rigorous method requires the user to (1) search for papers that meet strict, user-defined 
criteria, (2) extract activity peaks from desired analyses in each paper, (3) convert activity 
peak coordinates to a common reference space, and (4) choose statistical settings for 
running the analysis (Laird et al., 2005). With respect to step (3), each person’s brain is a 
slightly different shape and size, to which end fMRI studies “normalize” participant 
brains to one of two common reference spaces: Talairach or MNI (Montreal Neurological 
Institute) space. MNI is a newer reference space that was created using a combination of 
hundreds of brains, making it more representative of the general public than Talairach 
space, which is based on a single individual’s brain. For the current study, all activity 
peaks were converted to MNI space.  
GingerALE uses an activation likelihood estimate (ALE) for conducting the meta-
analysis, which involves computing ALE values for each voxel (i.e., volumetric pixel) in 
the brain to determine whether activity in that voxel was consistently reported across 
studies (Laird et al., 2003). Significant clusters of activity are then displayed in an ALE 
map. 
More specifically, GingerALE analyzes the spatial convergence of the peaks of 
activation for the studies as a set. First, GingerALE smooths the imperfect foci using a 
three-dimensional Gaussian function to get more accurate and useful estimates of the 
active regions. Next, these smoothed foci are put together into an ALE map which shows 
the pattern of activation across the set of studies selected for the meta-analysis. This map 
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reflects the likelihood that each voxel in the brain truly represents activation. Lastly, 
GingerALE uses a statistical threshold, set by the user, to calculate the common patterns 
of activation across the set of studies. This ALE map is compared to another ALE map in 
which an equivalent number of peaks of activation are randomly generated. GingerALE 
compares the true pattern of activation to this random distribution to determine whether 
the pattern is more likely to be found than a chance distribution (Levy & Wagner, 2011). 
I conducted two analyses on each set of data; the first a stringent analysis that corrects for 
multiple comparisons, and the second more exploratory. For the stringent analysis, I used 
a cluster-level family-wise error of p < 0.05 to correct for multiple comparisons, 
following an initial cluster forming threshold of uncorrected p < 0.001. For the 
exploratory analysis, I used a cluster forming threshold of uncorrected p < 0.001 and a 
minimum cluster volume of 300 mm3. GingerALE analyses were performed using 
GingerALE version 2.3.6), using the standard default parameters 
(http://brainmap.org/ale/).  
Using the above approach, I conducted three separate meta-analyses. The first 
examined areas of the brain showing hyperactivity in MDD relative to controls (MDD > 
HC) during emotion processing tasks, and the second examined areas of the brain 
showing hypoactivity in MDD relative to controls during such tasks (HC > MDD). I then 
repeated the first analysis (MDD > HC) to specifically focus on studies that evaluated 
responses to negative vs. neutral stimuli, i.e., I removed studies that utilized positive 
stimuli or a mix of positive and negative stimuli. Unfortunately, there were insufficient 
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data to conduct a similar analysis focusing only on those studies utilizing positive vs. 
























Hyperactivation in MDD 
The first analysis used the contrast MDD > HC to examine areas of hyperactivation in 
MDD relative to controls when performing an emotion processing task. The analysis was 
based on 187 foci across 25 studies. Using a stringent threshold, this analysis revealed 
one significant cluster that covered the right amygdala and ventral portions of the 
putamen and globus pallidus (Figure 1). The exploratory analysis using a more lenient 
threshold revealed the same right amygdala cluster and additional clusters in the left 
amygdala and hippocampus, left nucleus accumbens, and right Brodmann areas 46 and 
47 within the inferior frontal gyrus (Figure 2).  
 
 
Figure 1. Cluster of activation for the stringent MDD > HC contrast. (A) denotes a 
significant cluster that covers the right amygdala and ventral portions of the putamen and 






Figure 2. Clusters of activation for the exploratory MDD > HC contrast. (A) denotes the 
right amygdala and ventral portions of the putamen and globus pallidus, (B) denotes the 
left amygdala and hippocampus, (C) denotes the left nucleus accumbens, and (D) denotes 
Brodmann areas 46 and 47 in the right inferior frontal gyrus.  
 
Hypoactivation in MDD 
Next, I conducted a meta-analysis using the reverse contrast of HC > MDD to 
examine areas that were hypoactive in individuals with MDD relative to controls when 
performing an emotion processing task. The analysis was based on 117 foci across 15 
studies. Using a stringent threshold, this analysis did not reveal any significant clusters. 
However, an exploratory analysis using a more lenient threshold returned one significant 
cluster in Brodmann area 9 in the right dorsolateral prefrontal cortex (Figure 3).  
 
Figure 3. Cluster of activation for the exploratory HC > MDD contrast. (A) denotes one 





The remaining meta-analysis was designed to examine whether the observed 
hyperactivity in MDD relative to controls held when focusing specifically on those 
studies that evaluated responses to negative vs. neutral stimuli. This analysis included 37 
foci across 7 studies. Using a stringent threshold, the analysis revealed two significant 
clusters: one in the left amygdala and parahippocampal gyrus, and the other in the right 
amygdala and ventral putamen (Figure 4). Using a more lenient threshold did not reveal 






Figure 4. Clusters of activation for the stringent Negative > Neutral contrast. (A) denotes 
the left amygdala and parahippocampal gyrus, and (B) denotes the right amygdala and 


















This study involved meta-analysis of fMRI data comparing brain activity in 
individuals with MDD and healthy controls during emotion processing tasks. The 
overarching aim was to identify areas of dysfunction consistently reported across studies, 
and thus potential areas for treatment. A series of analyses revealed areas of both 
hyperactivation and hypoactivation in individuals with MDD relative to controls. The 
right amygdala and ventral portions of the putamen and globus pallidus were found to be 
consistently hyperactive across studies when using a stringent statistical threshold. A 
more lenient exploratory analysis revealed additional hyperactivity in the MDD group in 
the left amygdala and hippocampus, left nucleus accumbens, and right Brodmann areas 
46 and 47 within the inferior frontal gyrus. These findings are consistent with my 
hypothesis that prefrontal cortex regions and the amygdala would be consistently more 
active in patients relative to controls when performing an emotion processing task. 
However, in contrast to my predictions, anterior cingulate cortex was not shown to be 
consistently hyperactive across studies. When repeating the hyperactivity meta-analysis 
to include only those studies utilizing negative vs. neutral stimuli, results revealed 
bilateral amygdala hyperactivity in MDD relative to controls. Finally, with respect to 
hypoactivity, no regions were found to be consistently less active in MDD than controls 
using a stringent threshold. However, an exploratory analysis revealed hypoactivity in the 
MDD group in Brodmann area 9 in the right dorsolateral prefrontal cortex. This finding 
somewhat supports my hypothesis; however, I did not find hypoactivity in the 




The hyperactivity findings in the current study largely support those of a previous 
meta-analysis conducted by Groenewold et al. (2013), who reported peaks of 
hyperactivation in the amygdala, striatum, parahippocampus, cerebellum, fusiform, and 
anterior cingulate cortex in individuals with MDD compared to healthy controls. Using a 
stringent statistical approach, I report hyperactivity in individuals with MDD in the 
amygdala and ventral portions of putamen and globus pallidus, regions that are linked to 
emotion regulation, emotion response, emotional memory, and emotional learning 
(LeDoux, 2000). In healthy individuals, previous studies have identified activation of the 
amygdala, insula, and anterior temporal lobe during emotion processing tasks 
(Beauregard, Paquette, & Le, 2006). However, as demonstrated by the current study, this 
amygdala activation is more extreme in individuals with MDD. It has been suggested that 
this hyperactivation is a product of reduced connectivity between the amygdala and a 
variety of brain regions involved in emotion processing and regulation, including the 
ventrolateral prefrontal cortex, insula, caudate, middle and superior temporal regions, 
occipital cortex, and cerebellum (Ramasubbu et al., 2014). Such reductions in 
connectivity may lead to dysfunction in bottom-up signaling, leading to altered emotional 
regulation.   
The hyperactivity cluster centered in the right amygdala also included ventral 
portions of the basal ganglia, specifically the putamen and globus pallidus. Normal basal 
ganglia function is associated with emotion processing, among other functions like motor 
control (Paradiso, Ostedgaard, Vaidya, Ponto, & Robinson, 2013). In healthy individuals, 
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previous fMRI studies have demonstrated increased reactivity to emotional stimuli 
(Paradiso et al., 2013), an effect that has been shown to be even more pronounced in 
individuals with MDD (Calder, Lawrence, & Young, 2001; Davis & Whalen, 2001; 
Lawrence et al., 2004; Paradiso et al, 2013). 
Using a more lenient statistical threshold, additional clusters of hyperactivity were 
found in the left amygdala, as well as the left nucleus accumbens and right Brodmann 
areas 46 and 47 within the inferior frontal gyrus. Given the exploratory nature of this 
analysis, caution is warranted when interpreting these results. The nucleus accumbens is 
part of the striatum and is considered part of the “reward pathway” as it typically shows 
activation for rewarding stimuli in healthy controls (Pizzagalli et al., 2009). In individuals 
with MDD, however, the nucleus accumbens often shows hyperactivation in response to 
negative stimuli (Monk et al., 2008). Results of the current study also demonstrated 
hyperactivity in portions of the inferior frontal gyrus that have been considered a pathway 
between the orbitofrontal cortex, associated with emotion processing, and premotor 
cortical areas, associated with movement (Cheng et al., 2016; Rolls, 2016; Rolls, 2018; 
Rolls, 2019; Rolls et al., 2020). These areas have also been hypothesized as ideal targets 
for therapies like DBS and TMS for treating symptoms of TRD like lack of motivation to 
perform actions (Pizzagalli et al., 2009; Rolls et al., 2020).  
I hypothesized that several regions would show hyperactivity, including  prefrontal 
cortex regions, anterior cingulate cortex, and bilateral amygdala. However, compared to 
Groenewold et al. (2013), I found fewer areas of hyperactivity. In particular, I did not 
find the anterior cingulate cortex to be hyperactive. This can likely be explained due to 
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using different and more stringent inclusion criteria. In contrast to Gronenewold et al. 
(2013) in the current study, I excluded papers that used the Monetary Incentive Delay, a 
task based on decision-making, as those papers did not meet my criteria that the tasks use 
emotional stimuli. Future studies could run analyses both with and without these tasks 
(e.g., emotional stimuli and decision-making) to evaluate the impact of this exclusion. 
Additionally, it is possible that neural hyperactivity could be a form of compensation, 
allowing individuals with MDD to more effectively engage in daily behavior. More 
research is needed to determine is needed to determine whether lowering activity levels 
in these regions results in a behavioral change.  
Hypoactivation 
Using a stringent statistical threshold, no regions were found to be consistently 
hypoactive in MDD relative to controls, but an exploratory analysis revealed hypoactivity 
in Brodmann area 9 in the right dorsolateral prefrontal cortex in the MDD group. As 
noted above, results of this exploratory analysis should be interpreted with caution. This 
finding is generally consistent with symptoms of MDD in that this region is associated 
with response inhibition; a reduced ability to engage in inhibitory processes could relate 
to increases in rumination (Aron, Fletcher, Bullmore, Sahakian, & Robbins, 2003; Picton, 
2007). Compared to my hypothesis, I found fewer regions of hypoactivity, likely because 
of using different and more stringent inclusion criteria.  
Stimulus Valence 
The final meta-analysis included only those studies focusing on negative stimuli, 
whereas the prior analyses included studies that utilized both positive and negative 
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stimuli. Results of this narrower analysis indicated that individuals with MDD showed 
amygdala hyperactivity relative to healthy controls when processing negative stimuli. 
These findings align with prior reports of exaggerated amygdala reactivity to negative 
emotional stimuli in individuals with MDD relative to controls (Ramasubbu et al., 2014; 
Stuhrmann et al., 2013). Other studies suggest that increased activity in the amygdala 
may also relate to repetitively thinking about or ruminating on negatively salient stimuli 
(Nejad, Fossati, & Lemogne, 2013; Whitmer & Gotlib, 2013).  
Although the current study did not investigate neural responses to positive stimuli due 
to insufficient data, other researchers have demonstrated that individuals with MDD show 
amygdala hypoactivity relative to controls in response to happy faces (Stuhrmann et al., 
2013). Furthermore, this hypoactivity was linked to anhedonia, or an inability to 
experience pleasure. When more studies are available, future research should involve 
meta-analyses comparing neural activity in MDD and controls when responding 
selectively to positive or negative stimuli. Groenewold et al. (2013) found hyperactivity 
in the medial orbitofrontal cortex in individuals with MDD compared to HC when 
processing positive stimuli. Because their inclusion and exclusion criteria were less 
stringent, they were able to include more studies for the Positive > Neutral analysis.  
Clinical Implications 
Current efficacious treatments for MDD include specific psychotherapies and 
pharmacotherapy; however, 50% of individuals with MDD do not respond to these 
treatments. A review of resting-state fMRI studies, or non-task based studies, showed 
several changes to the brain such as increased connectivity between some regions (e.g., 
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middle temporal gyrus to default mode network) and decreased connectivity between 
others (e.g., prefrontal cortex regions to temporo-limbic regions) when comparing pre-
treatment and post-treatment images for individuals treated with pharmacotherapies 
(Dichter et al., 2015). There are no such fMRI studies comparing pre- and post-treatment 
changes for psychotherapies.  
Other, newer treatments include forms of neural stimulation such as DBS and TMS, 
as well as intranasal ketamine (Pradhan, Parikh, Makani, & Sahoo, 2015). Preliminary 
findings from neurostimulation trials have revealed mixed findings in terms of the 
effectiveness of DBS and TMS (Filkowski & Sheth, 2019; Wang, 2019). A 2014 meta-
analysis of DBS in MDD found that the subgenual cingulate cortex showed the best 
results when targeted, while a 2010 study found identified the dorsolateral prefrontal 
cortex as a successfully targeted region (Janicak et al., 2010; Lipsman et al., 2014). 
Additionally, a 2008 study of TMS found success when targeting the left dorsolateral 
prefrontal cortex (Drevets, Price, & Furey, 2008). It bears noting that DBS is a more 
precise treatment than TMS, given that TMS is non-invasive. Additionally, TMS is well-
suited to stimulating cortical regions on the lateral surface but not deeper cortical or sub-
cortical areas. As such, DSB may be a more effective neurostimulation option for when 
stimulating the amygdala and ventral portions of the basal ganglia, whereas TMS may be 
the more appealing option for stimulating the dorsolateral prefrontal cortex.  
Limitations 
While powerful, a meta-analytic approach to analyzing common areas of activation 
across studies does come with limitations. First, although using specific inclusion and 
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exclusion criteria eliminated a large number of less relevant studies from the analysis, 
those that remained still differed from one another in many respects. For example, 
individual studies differed greatly in the number of participants, mean age of participants, 
mean length of diagnosis, and mean onset of diagnosis. The stimuli (e.g., words, faces, 
videos, etc.) and specific tasks (e.g., passive viewing, making emotional ratings, etc.) also 
differed across studies. It is unclear to what degree these differences may have influenced 
the results. As more studies on this topic are conducted in the future, new meta-analyses 
could be performed that allow for greater similarity across studies, e.g., by only including 
studies that use an emotion rating task. 
Second, the meta-analyses evaluating hypoactivity did not return significant results 
when using a stringent statistical threshold that controlled for multiple comparisons. As 
such, the exploratory results should be interpreted with caution. Third, in investigating 
the role of stimulus valence in contributing to neural dysfunction in MDD, I was only 
able to perform a meta-analysis focusing on negative vs. neutral stimuli given an 
insufficient number of studies examining positive vs. neutral stimuli. Two meta-analyses 
comparing neural dysfunction in MDD when processing negative vs. positive stimuli 
could help elucidate which areas would be most beneficial to target for treatment based 
on the presentation of symptoms. For instance, studies have demonstrated a link between 
amygdala hyperactivity in MDD in response to negative stimuli and rumination, and 
others have shown a relationship between amygdala hypoactivity in response to positive 
stimuli and anhedonia (Bradley, & Cuthbert, 1997; Canli et al., 2004; Jenkins et al., 2017; 




The combined results of these meta-analyses suggest that the amygdala and ventral 
portions of the basal ganglia are hyperactive in individuals with MDD relative to controls 
when performing emotion processing tasks. This hyperactivity held when the analysis 
focused specifically on studies using negative stimuli. Conversely, an exploratory 
analysis suggests that BA9 (right dorsolateral prefrontal cortex) may be hypoactive in 
individuals with MDD relative controls. These regions could be targeted when using 
neurostimulation approaches, such as DBS and TMS, in an effort to improve upon the 
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